You can buy or sell INmune Bio and other stocks, options, ETFs, and crypto commission-free!
INmune Bio Inc. Common stock, also called INmune Bio, is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Read More Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
La Jolla, California
52 Week High
52 Week Low
Expected Feb 14, Pre-Market